Skip to main content
Top
Published in: Clinical and Translational Oncology 10/2007

01-10-2007 | Special Article

Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals

Authors: F. C. Muñoz-Casares, S. Rufián, M. J. Rubio, E. Lizárraga, C. Díaz-Iglesias, E. Aranda, R. Ciria, J. Muntané, P. Barrios, J. Torres-Melero, S. González-Moreno, L. González-Bayón, B. Camps, P. Bretcha, J. Farré, G. Ortega-Pérez, A. Gómez-Portilla

Published in: Clinical and Translational Oncology | Issue 10/2007

Login to get access
Metadata
Title
Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals
Authors
F. C. Muñoz-Casares
S. Rufián
M. J. Rubio
E. Lizárraga
C. Díaz-Iglesias
E. Aranda
R. Ciria
J. Muntané
P. Barrios
J. Torres-Melero
S. González-Moreno
L. González-Bayón
B. Camps
P. Bretcha
J. Farré
G. Ortega-Pérez
A. Gómez-Portilla
Publication date
01-10-2007
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 10/2007
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-007-0118-0

Other articles of this Issue 10/2007

Clinical and Translational Oncology 10/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine